ArticleBMC nursing2026
Psychiatric nurse-delivered Eye Movement Desensitization and Reprocessing (EMDR) for adults with moderate to severe post-traumatic stress symptoms in Jordan: a preliminary randomized controlled trial.
Article in BMC nursing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07423832 (Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Psychiatric Nurse-Delivered Eye Movement Desensitization and Reprocessing (EMDR) for Adults With Post-Traumatic Stress Symptoms in Jordan: A Randomized Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPost-traumatic stress disorder (PTSD) is associated with substantial psychological, social, and functional impairment. Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based trauma-focused intervention; however, evidence regarding its delivery by psychiatric nurses remains limited, particularly in Middle Eastern settings. This study evaluated the effectiveness of psychiatric nurse-delivered EMDR for reducing post-traumatic stress symptoms among Jordanian adults.
methodsA two-arm randomized controlled trial with repeated measurements was conducted among 70 adults experiencing moderate to severe post-traumatic stress symptoms. Participants were randomly allocated to either nurse-delivered EMDR therapy (n = 35) or a waitlist control group (n = 35). PTSD symptom severity was assessed using the Primary Care PTSD Screen (PC-PTSD) at baseline, immediately following the intervention, and at one-month follow-up. Repeated-measures ANOVA and ANCOVA were used to evaluate intervention effects over time.
resultsParticipants receiving EMDR demonstrated significantly greater reductions in PTSD symptom scores compared with the waitlist control group at both post-intervention and one-month follow-up assessments. Mean PC-PTSD scores in the EMDR group decreased from 3.71 ± 0.67 at baseline to 2.34 ± 0.68 post-intervention and 0.03 ± 0.17 at one-month follow-up, compared with 3.77 ± 0.43, 3.10 ± 0.56, and 2.70 ± 0.59, respectively, in the waitlist control group. Repeated-measures analyses revealed significant effects of time [F(1,68) = 781.45, p < .001], group [F(1,68) = 159.9, p < .001], and the group × time interaction [F(1,68) = 224.27, p < .001]. After adjustment for sociodemographic and health-related covariates, the intervention effect remained statistically significant [F(1,56) = 127.1, p < .001]. Among the covariates examined, only age was significantly associated with PTSD symptom severity over time [F(1,56) = 4.14, p = .045, partial η²=0.070].
conclusionsNurse-delivered EMDR was associated with significant and sustained reductions in PTSD symptom severity among Jordanian adults. These findings support the feasibility of integrating trained psychiatric nurses into the delivery of trauma-focused psychological interventions and highlight the potential of nurse-delivered EMDR to expand access to evidence-based mental health care. Larger multicenter randomized controlled trials with active comparison groups and longer follow-up periods are needed to confirm these findings. CLINICAL
trial registrationThis trial was registered on 14/02/2026 at ClinicalTrials.gov, identifier [NCT07423832]. CLINICAL TRIAL NUMBERS: [ NCT07423832 ].
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.